Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001108205-26-000068
Filing Date
2026-06-05
Accepted
2026-06-05 09:06:26
Documents
4
Period of Report
2026-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A curis_2026specialmeetingrs.htm DEF 14A 275708
2 curisinc_vxprxyxs39460x269.jpg GRAPHIC 463986
3 curisinc_vxprxyxs39460x269a.jpg GRAPHIC 288093
4 image_0.jpg GRAPHIC 13933
  Complete submission text file 0001108205-26-000068.txt   1331360
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30347 | Film No.: 261067034
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)